GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 14.446
EU - Europa 8.070
AS - Asia 6.344
SA - Sud America 974
Continente sconosciuto - Info sul continente non disponibili 295
AF - Africa 149
OC - Oceania 54
Totale 30.332
Nazione #
US - Stati Uniti d'America 14.117
SE - Svezia 2.338
IT - Italia 2.171
SG - Singapore 2.069
CN - Cina 1.513
GB - Regno Unito 1.374
VN - Vietnam 732
HK - Hong Kong 720
BR - Brasile 687
DE - Germania 567
BD - Bangladesh 317
RU - Federazione Russa 312
FI - Finlandia 267
FR - Francia 258
UA - Ucraina 176
TR - Turchia 153
CA - Canada 150
ID - Indonesia 149
KR - Corea 142
IN - India 125
MX - Messico 96
AR - Argentina 92
NL - Olanda 90
BG - Bulgaria 84
IE - Irlanda 61
IQ - Iraq 56
JP - Giappone 56
BE - Belgio 55
AU - Australia 52
PL - Polonia 50
ES - Italia 49
EC - Ecuador 44
ZA - Sudafrica 43
VE - Venezuela 40
PK - Pakistan 37
AE - Emirati Arabi Uniti 34
CL - Cile 30
CO - Colombia 30
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
MY - Malesia 24
AL - Albania 23
AT - Austria 22
CH - Svizzera 22
LT - Lituania 22
RO - Romania 20
MA - Marocco 19
JO - Giordania 18
NP - Nepal 17
PH - Filippine 17
SA - Arabia Saudita 17
KE - Kenya 16
DZ - Algeria 15
EG - Egitto 15
PE - Perù 15
PT - Portogallo 15
IR - Iran 14
UY - Uruguay 14
BZ - Belize 13
IL - Israele 13
CR - Costa Rica 11
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
TN - Tunisia 10
DO - Repubblica Dominicana 9
MD - Moldavia 9
RS - Serbia 9
ET - Etiopia 8
PA - Panama 8
BO - Bolivia 7
BY - Bielorussia 7
JM - Giamaica 7
LB - Libano 7
NI - Nicaragua 7
SI - Slovenia 7
TH - Thailandia 7
TW - Taiwan 7
GT - Guatemala 6
SN - Senegal 6
BB - Barbados 5
CY - Cipro 5
GR - Grecia 5
HN - Honduras 5
LK - Sri Lanka 5
MT - Malta 5
SY - Repubblica araba siriana 5
DK - Danimarca 4
HR - Croazia 4
NG - Nigeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AM - Armenia 3
EE - Estonia 3
GE - Georgia 3
GY - Guiana 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
Totale 29.988
Città #
Stockholm 1.795
Ashburn 1.595
Singapore 1.400
Fairfield 1.345
Santa Clara 1.254
Southend 798
Chandler 745
Hong Kong 699
Woodbridge 697
San Jose 694
Houston 612
Council Bluffs 492
Seattle 480
Cambridge 438
Ann Arbor 422
Wilmington 422
Nyköping 346
Hefei 328
Beijing 318
Modena 307
New York 288
Los Angeles 287
London 273
Dearborn 263
Jacksonville 254
Ho Chi Minh City 224
Bologna 218
Helsinki 200
Hanoi 190
Milan 182
The Dalles 161
Chicago 159
Munich 136
Seoul 133
San Diego 131
Jakarta 121
Frankfurt am Main 107
Shanghai 99
Lauterbourg 84
Princeton 84
Moscow 79
Buffalo 78
Dallas 78
Sofia 78
Izmir 77
Parma 68
São Paulo 67
Fremont 63
Orem 62
Rome 61
Eugene 58
Boardman 56
Columbus 56
Dublin 56
Phoenix 52
Salt Lake City 50
Brussels 48
Bremen 42
Montreal 41
Mexico City 40
Tokyo 39
Guangzhou 38
Warsaw 37
Atlanta 35
Reggio Emilia 35
Da Nang 34
Nuremberg 33
Chennai 32
San Giuliano Milanese 31
Falls Church 30
Denver 29
Hillsboro 29
Toronto 29
Brooklyn 26
Haiphong 26
Johannesburg 26
Redwood City 26
Tampa 25
Amsterdam 24
Elk Grove Village 24
Grafing 23
Manchester 23
Poplar 23
Rio de Janeiro 23
Florence 22
Lancaster 22
Norwalk 22
Baghdad 21
Des Moines 21
Naples 21
Ravenna 21
Redondo Beach 21
San Francisco 21
Sydney 21
Boston 20
Mumbai 20
Portsmouth 20
Tashkent 20
Turku 18
Paris 17
Totale 21.019
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.225
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 511
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 504
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 484
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 462
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 435
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 432
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 430
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 426
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 419
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 400
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 399
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 398
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 392
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 391
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 381
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 381
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 374
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 367
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 365
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 364
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 350
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 350
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 348
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 343
Tumor Stroma Manipulation By MSC 342
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 341
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 340
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 335
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 332
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 331
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 330
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 329
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 322
Detection of microparticles from human red blood cells by multiparametric flow cytometry 320
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 318
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 312
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 310
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 309
GD2 CAR T cells against human glioblastoma 300
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 297
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 293
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 292
An adoptive immuno-gene therapy approach targeting neuroblastoma. 291
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 286
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 283
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 283
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 282
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 280
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 277
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 276
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 273
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 273
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 264
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 264
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 259
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 257
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 250
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 250
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 249
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 248
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 248
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 248
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 246
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 244
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 243
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 243
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 241
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 238
Cancer stem cells and their microenvironment. 238
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 232
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 232
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 229
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 227
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 227
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 217
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 216
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 214
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 209
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 207
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 194
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 191
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 190
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 188
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 183
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 181
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 180
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 174
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 170
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 167
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 164
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 163
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 161
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 158
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 142
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 142
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 138
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 136
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 121
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 115
Totale 30.186
Categoria #
all - tutte 110.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.876 0 0 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202611.389 633 332 669 1.134 1.592 559 1.170 470 2.678 993 719 440
2026/2027938 263 547 128 0 0 0 0 0 0 0 0 0
Totale 30.332